Early T-cell precursor acute lymphoblastic leukaemia

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Early T-cell precursor (ETP) leukaemias represent a recently identified subtype of T-cell acute lymphoblastic leukaemia (T-ALL).
• ETP T-ALL is characterized by a poor prognosis, highlighting the need for further research into its unique biological features.

Purpose of the Study:

• To review recent advancements in understanding the biology and genetics of ETP T-ALL.
• To explore the prognostic significance of ETP T-ALL.
• To identify potential new therapeutic strategies for this aggressive leukaemic subtype.

Main Methods:

• Immunophenotypic analyses to define ETP T-ALL.
• Transcriptional profiling to compare ETP T-ALL with other leukaemic subtypes.
• Genetic analyses to identify characteristic mutations and lesions.

Main Results:

• ETP T-ALL is immunophenotypically distinct and associated with a poor prognosis.
• Transcriptionally, ETP T-ALLs resemble haematopoietic stem cells and myeloid progenitors.
• ETP T-ALLs exhibit fewer typical T-ALL genetic lesions (e.g., CDKN2A/B deletions, NOTCH1 mutations) and more AML-associated mutations.

Conclusions:

• ETP T-ALL and early immature T-ALLs show a very early differentiation arrest with unique genetic and transcriptional profiles.
• These leukaemias bridge characteristics of both T-ALL and AML.
• The distinct biology and poor prognosis of ETP T-ALL underscore the urgent need for tailored therapeutic approaches.